ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0992

Inflammatory Arthritis in HIV-Infected Humanized Mice

Can Sungur1, Ayse Ozanturk1, Hongbo Gao1, Li-ping Yang1, Liang Shan1 and Wayne Yokoyama2, 1Washington University, St Louis, MO, 2Washington University School of Medicine, St. Louis, MO

Meeting: ACR Convergence 2021

Keywords: Arthritis, Infectious, HIV, innate immunity, Natural Killer Cells, Spondylarthropathies

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: Innate Immunity Poster (0992–1006)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Human immunodeficiency virus (HIV) remains a significant life-threatening agent and burden on public health. Lesser studied and understood aspects of HIV include HIV-associated inflammatory arthritis. By utilizing humanized mice with human cytokine knock-ins that better support a human immune system than other models, we studied HIV-associated arthritis and enthesitis to understand their development and progression.

Methods: MISTRG-IL15 mice (human M-CSF/GM-CSF, IL-3, SIRPα, TPO, RAG2 -/-, IL2rg-/-, and IL-15 knocked into the respective endogenous mouse loci) were reconstituted with CD34+ hematopoietic stem cells obtained from human fetal cord blood. After checking for engraftment after 6-8 weeks, we infected reconstituted mice with HIV. Synovial tissues were obtained from the knee joints of the hind limbs at different time points and processed into single cell suspensions. Intercellular staining was performed on cells incubated with PMA/Ionomycin for 4 hours and then permeabilized and fixed for flow cytometry. NK cells were defined as CD3-CD56+. Histochemistry was also performed on hind paws that were fixed in 4% paraformaldehyde. Samples were then sectioned and stained with H&E for histologic analysis. Different chemokine receptor-tropic HIV viruses were also utilized to determine importance of specific infected cells on development of inflammation.

Results: Humanized MISTRG-IL15 mice developed inflammatory arthritis as well as enthesitis after HIV infection. Significant increases in total inflammatory cells and NK cells were seen in the synovial tissue throughout the course of infection. GM-CSF producing NK cells also increased throughout the course of HIV infection. Late in the course of infection, IFNγ- and granzyme B-producing NK cells increased, along with a pro-inflammatory environment in the synovial tissue. Histologic analysis showed increased cellular infiltrate in the synovium and tendons of mice infected by HIV infection with erosive changes that worsened during course of infection. Antiretroviral therapy (ART) eliminated cellular infiltration while cessation of therapy resulted in return of cellular infiltration in synovial tissue. Use of a chemokine receptor-tropic HIV virus that does not infect macrophages (X4-tropic) showed reduced pro-inflammatory cytokine production by NK cells, strongly suggesting HIV-infected macrophages induced the NK cell changes.

Conclusion: We have developed a unique humanized mouse model of HIV infection which allows opportunities to study HIV-associated arthritis and enthesitis in depth. In addition to providing a model to study arthritis induced by other human pathogens, findings from such studies will provide mechanistic understanding of inflammatory arthritis and enthesitis.


Disclosures: C. Sungur, None; A. Ozanturk, None; H. Gao, None; L. Yang, None; L. Shan, None; W. Yokoyama, None.

To cite this abstract in AMA style:

Sungur C, Ozanturk A, Gao H, Yang L, Shan L, Yokoyama W. Inflammatory Arthritis in HIV-Infected Humanized Mice [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/inflammatory-arthritis-in-hiv-infected-humanized-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammatory-arthritis-in-hiv-infected-humanized-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology